Reflux Esophagitis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2023-02-01
Clinical Trial Update: Trimebutine Maleate Combined With Rabeprazole in Patients With Grade A or B Reflux Esophagitis Whose Symptoms Refractory to Rabeprazole [Phase 4]
Phase 4 trial of trimebutine maleate combined with rabeprazole for refractory reflux esophagitis was withdrawn.